Decline in Number of Clinical Trials for Alzheimer’s Disease (BBC News / Alzheimer’s Research & Therapy)

Summary

More than 99% of drug trials for Alzheimer’s Disease during the past decade have failed. An article in the Alzheimer’s Research & Therapy journal discusses an issue which was perhaps the key focus of the Global Dementia Legacy Event. Only one new medicine has been approved since 2004; 99.6% of drug trials aimed at preventing, curing or improving the symptoms of Alzheimer’s Disease between 2002 and 2012 either failed or were discontinued.

Full Text Link

Reference

Briggs, H. (2014). Decline in trials for Alzheimer’s disease. London: BBC Health News, July 3rd 2014.

This relates to:

Full Text Link

Reference

Cummings, JL. Morstorf, T. [and] Zhong, K. (2014). Alzheimer’s disease drug-development pipeline: few candidates, frequent failures. Alzheimer’s Research & Therapy, July 3rd 2014. 6: 37.

[A version of this item features in Dementia: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 12, July 2014].

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Alzheimer’s Disease International (ADI), Alzheimer’s Research UK, BBC News, Charitable Bodies, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Pharmacological Treatments, Quick Insights, Standards, Universal Interest and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.